Windlas Biotech Limited
NSE:WINDLAS.NS
859.85 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||||
Net Income
| 169.93 | 150.98 | 140.31 | 120.65 | 114.44 | 91.88 | 121.94 | 98 | 147.88 | 83.14 | 83 | 66.87 | 58.96 | 122.82 | 94.38 | -117.82 | 4.63 |
Depreciation & Amortization
| 0 | 33.89 | 33.3 | 31.89 | 35.68 | 31.35 | 29.05 | 0 | 0 | 0 | 0 | 0 | 32.69 | 29.31 | 0 | 0 | 23.8 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 10.08 | 0 | 0 | 0 | 4.55 | 4.82 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 212.65 | -261.7 | 0 | 0 | -59.11 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 147.34 | -188.53 | 0 | 0 | 119.92 |
Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 53.1 | -17.02 | 0 | 0 | -181.55 |
Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12.21 | -56.15 | 0 | 0 | 2.52 |
Other Non Cash Items
| -169.93 | -150.98 | -140.31 | -120.65 | -124.52 | -91.88 | -121.94 | -98 | -152.43 | -87.96 | -83 | -66.87 | -355.25 | 27 | -94.38 | 117.82 | 0.29 |
Operating Cash Flow
| 0 | 67.78 | 66.6 | 63.78 | 10.08 | 62.7 | 58.1 | 0 | 4.55 | 4.82 | 0 | 0 | -50.95 | -82.57 | 0 | 0 | -30.39 |
Investing Activities: | |||||||||||||||||
Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -9.85 | -21.84 | 0 | 0 | -39.75 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 118.26 | 38.2 | 0 | 0 | 159.28 |
Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 108.41 | 16.36 | 0 | 0 | 119.53 |
Financing Activities: | |||||||||||||||||
Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.3 | -40.85 | 0 | 0 | -13.47 |
Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 78.43 | 108.91 | 0 | 0 | 74.19 |
Financing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 73.13 | 68.06 | 0 | 0 | 60.72 |
Other Information: | |||||||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 26.85 | 0 | 0 | 30.92 |
Net Change In Cash
| 0 | 67.78 | 66.6 | 63.78 | 10.08 | 62.7 | 58.1 | 0 | 4.55 | 4.82 | 0 | 0 | 130.6 | 28.7 | 0 | 0 | 180.78 |
Cash At End Of Period
| 0 | 342.06 | 274.28 | 100.64 | 36.86 | 1,067.54 | 1,004.84 | 0 | 4.55 | 4.82 | 0 | 159.3 | 159.3 | 28.7 | 0 | 180.78 | 180.78 |